Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Head and Neck Cancers
•
Radiation Oncology
Do you employ a phrenic nerve dose constraint with conventional fractionation?
E.g. breast or H&N cancers when boosting the supraclav area.
Answer from: Radiation Oncologist at Academic Institution
No.
Sign in or Register to read more
14494
Related Questions
What is the role of radiation therapy for an elderly patient with medullary thyroid cancer who is not a surgical candidate?
What is the significance of LVSI in determining post-op management for oropharyngeal cancer?
How do you manage the thickened secretions secondary to xerostomia during head and neck radiation?
For very large locally advanced head and neck primary malignancies (namely SCCa), how do you decide between adaptive re-planning of a VMAT/IMRT plan during chemo-RT as option instead of induction chemotherapy?
What are the indications, doses, and volumes for postoperative radiation for parathyroid carcinomas?
What would be your approach to the treatment of limited stage extrapulmonary small cell carcinoma of the nasopharynx with bilateral cervical lymphadenopathy?
What is your approach to adjuvant radiotherapy for head and neck cancer after resection and reconstruction with a free tissue (muscle and bone) flap?
In which scenarios, would you consider a planned neck dissection following definitive radiation therapy?
What dose and fractionation would you use for Kaposi’s sarcoma of the tonsil post op?
How would you treat a patient with p16 (-) neck lymph node metastasis of an unknown primary, considering their history of prior supraclavicular and chest wall irradiation?